Full video transcriptClick to expand
Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00What is an average dosage of testosterone replacement therapy? Now, when you first get started on
- 0:04TRT for the first time in your life, most men are getting started on anywhere between about 90
- 0:09milligrams of testosterone upwards of 150 per week to see higher body response to that. Three months
- 0:14after you get started as a patient here at Harley-Meds, we're going to take a blood test to see where
- 0:19your levels are and making sure they're working into that optimized range. And that's our whole goal.
- 0:22Here at Harley-Meds is to make sure you're staying fully optimized. If you want to work with a clinic
- 0:27that truly cares about your health, doesn't just treat you like a freaking number, comment the word
- 0:30TRT down in the comments below and let's get you to switch over to Harley-Meds ASAP.
TRT dosing claims on TikTok: what fitness creators get wrong
Quick answer
The creator describes a standard initiation protocol for injectable testosterone therapy using a weekly dosing window of 90-150 mg, followed by serum testosterone testing at three months. This aligns with common telehealth TRT practice but omits required clinical individualization based on baseline labs, hematocrit, and cardiovascular risk. The video is explicit promotional content for Harley-Meds and should be evaluated with that context in mind.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT dosing claims on TikTok: what fitness creators get wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT dosing claims on TikTok: what fitness creators get wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT dosing claims on TikTok: what fitness creators get wrong" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes a standard initiation protocol for injectable testosterone therapy using a weekly dosing window of 90-150 mg, followed by serum testosterone testing at three months.
The reason this review is not generic is the source wording and the canonical claim label "trt trt dose." In this clip, the useful excerpt is: "What is an average dosage of testosterone replacement therapy?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator describes a standard initiation protocol for injectable testosterone therapy using a weekly dosing window of 90-150 mg, followed by serum testosterone testing at three months.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes a standard initiation protocol for injectable testosterone therapy using a weekly dosing window of 90-150 mg, followed by serum testosterone testing at three months. This aligns with common telehealth TRT practice but omits required clinical individualization based on baseline labs, hematocrit, and cardiovascular risk. The video is explicit promotional content for Harley-Meds and should be evaluated with that context in mind.
- The 90-150 mg per week starting range for injectable testosterone is within common clinical use, but the Endocrine Society recommends individualized dosing, not a standard window for all patients.
- Three-month follow-up bloodwork is genuinely standard of care for TRT initiation, per Bhasin et al. 2018 in the Journal of Clinical Endocrinology and Metabolism.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The 90-150 mg per week starting range for injectable testosterone is within common clinical use, but the Endocrine Society recommends individualized dosing, not a standard window for all patients.
- Three-month follow-up bloodwork is genuinely standard of care for TRT initiation, per Bhasin et al. 2018 in the Journal of Clinical Endocrinology and Metabolism.
- Erythrocytosis (elevated red blood cell count) occurs in up to 44% of patients on injectable testosterone regimens, per Ramasamy et al. (2021, Translational Andrology and Urology), and requires monitoring beyond just testosterone levels.
- No clinical guideline defines a universal 'optimized' testosterone range. The Endocrine Society targets the mid-normal range for age-matched healthy men, which varies between individuals.
- Any legitimate TRT provider should complete comprehensive baseline labs, including serum testosterone, hematocrit, PSA, and metabolic panels, before initiating therapy.
- This video is promotional content for a specific clinic. The clinical information is partially accurate but exists to drive patient acquisition, not purely to educate.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The creator claims that men starting TRT for the first time typically begin on "anywhere between about 90 milligrams of testosterone upwards of 150 per week." They also say patients at their clinic, Harley-Meds, get a follow-up blood test at three months to check whether levels have reached an "optimized range." The video ends as a direct recruitment pitch: comment "TRT" to switch clinics.
To be clear, this is promotional content for a specific telehealth clinic. That framing matters when you're evaluating whether the medical information is educational or exists primarily to sell a service. Both can be true at once, but viewers should know which one they're watching.
Does the science back this up?
The dose range cited is broadly consistent with clinical practice, but the phrasing glosses over important nuance. Testosterone cypionate and enanthate are typically initiated between 75 mg and 200 mg per week in real-world clinical settings, so the 90-150 mg window isn't invented. However, dosing is not a one-size range.
A 2020 paper by Mulhall et al. in the Journal of Urology reviewing AUA guidelines notes that starting doses should be individualized based on baseline serum testosterone, symptom burden, hematocrit, and cardiovascular risk profile. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) recommend targeting mid-normal physiologic testosterone levels, which varies considerably between patients. Saying 90-150 mg is the standard start implies more uniformity than actually exists in evidence-based prescribing.
What did they get wrong (or right)?
Credit where it's due: the three-month follow-up blood test is genuinely standard practice and the creator gets this right. Bhasin et al. 2018 specifically recommends measuring serum testosterone 3-6 months after initiation, along with hematocrit and PSA in appropriate patients. Monitoring is not optional, it's the mechanism by which dosing is adjusted safely.
What the creator gets wrong, or at least incomplete: the phrase "optimized range" is doing a lot of unscrutinized work here. There is no universally agreed clinical definition of "optimized" testosterone. The Endocrine Society targets the mid-normal range for age-matched healthy men. Some telehealth clinics push levels toward the upper end of normal or beyond, which increases risks including erythrocytosis, sleep apnea exacerbation, and suppression of endogenous production. The video presents optimization as a simple, shared goal without explaining what that range is, who sets it, or what the tradeoffs are.
- The dose range cited (90-150 mg/week) is within typical clinical use but not universally appropriate.
- Three-month bloodwork is accurate and genuinely good practice.
- "Optimized range" is marketing language, not a defined clinical target.
What should you actually know?
If you're considering TRT, the dose range mentioned is a reasonable ballpark, but it is a starting point for a conversation with a prescriber, not a prescription. Your actual starting dose should depend on your baseline testosterone level confirmed by morning serum testing, your symptoms, your hematocrit, your age, and your cardiovascular history.
Three-month monitoring is the floor, not the ceiling. Safe TRT protocols also include hematocrit checks, because testosterone raises red blood cell production and elevated hematocrit increases clotting risk. A 2021 review by Ramasamy et al. in Translational Andrology and Urology found that erythrocytosis is the most common adverse effect of injectable testosterone, occurring in up to 44% of patients on certain regimens. That is not a minor footnote.
Finally, any clinic, including Harley-Meds, should be evaluated on whether they do comprehensive intake labs, monitor regularly, and adjust doses based on your individual response. A comment on TikTok is not a clinical intake. A good telehealth TRT provider will run labs before prescribing anything.
Is this video trustworthy?
Partially. The core clinical information about dosing ranges and follow-up labs is not fabricated. But this is a sales video dressed as education, and the "optimized range" language is vague enough to justify almost any prescribing decision. Viewers should treat this as a starting point for asking better questions, not as clinical guidance.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
9.9K views on this video
TRT Dose?
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the 90-150 mg per week starting range for injectable testosterone?
The 90-150 mg per week starting range for injectable testosterone is within common clinical use, but the Endocrine Society recommends individualized dosing, not a standard window for all patients.
What does the video say about three-month follow-up bloodwork?
Three-month follow-up bloodwork is genuinely standard of care for TRT initiation, per Bhasin et al. 2018 in the Journal of Clinical Endocrinology and Metabolism.
What does the video say about erythrocytosis (elevated red blood cell count) occurs in up to?
Erythrocytosis (elevated red blood cell count) occurs in up to 44% of patients on injectable testosterone regimens, per Ramasamy et al. (2021, Translational Andrology and Urology), and requires monitoring beyond just testosterone levels.
What does the video say about no clinical guideline defines a universal 'optimized' testosterone range. the?
No clinical guideline defines a universal 'optimized' testosterone range. The Endocrine Society targets the mid-normal range for age-matched healthy men, which varies between individuals.
What does the video say about any legitimate trt provider should complete comprehensive baseline labs, including?
Any legitimate TRT provider should complete comprehensive baseline labs, including serum testosterone, hematocrit, PSA, and metabolic panels, before initiating therapy.
What does the video say about this video?
This video is promotional content for a specific clinic. The clinical information is partially accurate but exists to drive patient acquisition, not purely to educate.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.